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Ascorbic acid (AA) has been reported to be both pro-and antiglycating agent. In vitro, mainly proglycating
effects of AA have been observed. We studied the glycation of bovine serum albumin (BSA) induced by
AA in vitro. BSA glycation was accompanied by oxidative modiﬁcations, in agreement with the idea of
glycoxidation. Glycation was inhibited by antioxidants including polyphenols and accelerated by 2,2′-
azobis-2-methyl-propanimidamide and superoxide dismutase. Nitroxides, known to oxidize AA, did not
inhibit BSA glycation. A good correlation was observed between the steady-state level of the ascorbyl
radical in BSA samples incubated with AA and additives and the extent of glycation. On this basis we
propose that ascorbyl radical, in addition to further products of AA oxidation, may initiate protein gly-
cation.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
One of unavoidable posttranslational protein modiﬁcations is
the non-enzymatic glycosylation (glycation). Protein glycation is
initiated by a nucleophilic addition reaction between the free
amino group of a protein, lipid or nucleic acid and the carbonyl
group of a reducing saccharide or aldehyde. This reaction forms a
reversible Schiff base, which rearranges over a period of days to
generate Amadori products. The Amadori products undergo de-
hydration and rearrangements followed by other reactions such as
cyclization, oxidation, and dehydration to form more stable Ad-
vanced Glycation End Products (AGEs) [1,2].
Many substances affect protein glycation, some promoting and
some inhibiting this process. One of such compounds is ascorbic
acid (AA), a key exogenous non-enzymatic antioxidant present in
plasma and within cells. In the general population the assumed
optimal plasma AA concentration of 50 mM, as proposed by a
consensus conference, can be achieved by the intake of 100 mg of
vitamin C per day, which is the new recommendation of the
Austrian, German, and Swiss Nutrition Societies [3]. AA has been
reported to be both an anti- and proglycating agent. Numerous
studies have demonstrated mainly pro-glycating activity of AA in
in vitro systems and mainly anti-glycating activity of this com-
pound in vivo [4–11].B.V. This is an open access article u
a-Bartosz).A simple explanation of these divergent results implies that AA
oxidation products i.e. dehydroascorbic acid (DHA) and com-
pounds formed by its decomposition, and not AA itself are the
glycating agents in AA-containing systems. Unlike AA, DHA is
unstable both in the absence and in the presence of oxygen, and is
a reactive electrophile, which generates further reactive degrada-
tion products over time in solution. These electrophilic products
react with nucleophiles on proteins, speciﬁcally lysinyl and arginyl
residues, resulting in structurally deleterious, non-enzymatic
modiﬁcations of proteins. Increases in DHA degradation have been
involved in the etiology of a variety of diseases, including age-re-
lated cataract [9,12], diabetes [13] and Alzheimer's disease [14].
These diseases have all been associated with increases in ROS
production and protein glycation.
Although glycation of long-lived proteins is the most important
from the physiological point of view, the effect of glycation on
shorter-living proteins like plasma albumin is also of interest as
their properties and functions may be affected by this process.
Many in vitro glycation experiments have been done on human
serum albumin and bovine serum albumin (BSA) which has high
(76%) sequence homology to human serum albumin. The glycation
of albumin induces several structural and functional modiﬁcations,
including alterations in ligand binding [15,16].
We have found previously that AA enhanced BSA glycation
induced by sugars, especially glucose, and induced glycation itself
[17]. The aim of the present study was the characterization of the
AA-induced glycation of BSA and of the effects of variousnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Materials
All basic reagents were from Sigma-Aldrich Company (Poznań,
Poland) unless indicated otherwise. Genistein, 4-hydroxycinnamic
acid, naringin, quercetin and genkwanin were purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
Sample preparation
BSA (purity of 96%) was dissolved in 0.1 M sodium phosphate
buffer, pH 7.4, at a concentration of 0.09 mM. AA was used at a
concentration of 1 mM. The samples without or with selected
additives were incubated in closed vials at a temperature of 37 °C
for 6 days with 1 mM sodium azide as a preservative. The fol-
lowing water-soluble additives were used: 0.05, 0.1, 0.2, 0.5 and
1 mM nitroxides: 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO),
4-hydroxy-TEMPO and 4-carboxy-TEMPO; oxidants: 0.1 mM H2O2,
5 mM 2,2′-azobis-2-methyl-propanimidamide hydrochloride
(AAPH) and 1 mM FeCl3; antioxidants (1 mM): captopril, tiron and
trolox; metal chelators: ethylenediminetetraacetic acid (EDTA),
ethylene glycol tetraacetic acid (EGTA), diethylene-
triaminepentaacetic acid (DTPA) and nitrilotriacetic acid (NTA);
organic acids: 1-cyano-4-hydroxycinnamic acid, 4-hydro-
xycinnamic acid; polyphenols: caffeic acid, ellagic acid, ferulic
acid, gallic acid and propyl gallate. Genistein, genkwanin, naringin,
quercetin and rutin were dissolved in dimethylsulfoxide (DMSO)
so the level of glycoxidation found in samples containing AA and
DMSO was used as a reference in these cases. The above con-
centrations of selected anti-glycating compounds had been ap-
plied in our earlier in vitro experiments [17–20].
In studies of the effects of the effects of addition of superoxide
dismutase (SOD) and catalase (CAT) on AA-induced BSA glycation,
10 mg/ml SOD and 10 mg/ml CAT were used.
AGE measurements
AGEs are a heterogeneous group of compounds with a char-
acteristic ﬂuorescence. AGEs were estimated by assessing the
formation of AGE-derived ﬂuorescence, termed glycophore, using
the spectroﬂuorimetric method according to Henle et al. [21] and
Münch et al. [22] at the excitation and emission wavelengths of
325 and 440 nm, respectively. Two hundred microliters of aliquots
were applied to a 96-well plate. In order to check the validity of
results based on the assay of ﬂuorimetric indices of BSA oxidative
damage, the AGEs content was also evaluated by enzyme-linked
immunosorbent assay (ELISA) Kit for Advanced Glycation End
Product (USCN Life Science Inc., Product no. CEB353Ge), according
to the instruction of the manufacturer. Increase in the AGE content
in samples incubated with AA only (in the absence of any potential
protectors) with respect to a sample incubated with AA only or AA
with DMSO (for compounds introduced from DMSO solutions) was
assumed as 100%; the increase in samples containing selected
anti-glycating protector was expressed as % of this value.
Content of dityrosine, kynurenine, and N′-formylkynurenine
The levels of dityrosine, kynurenine, N′-formylkynurenine and,
to a lesser extent, kynurenine ﬂuorescence are markers of protein
oxidation [23]. The content of dityrosine, kynurenine, N′-for-
mylkynurenine and kynurenine was estimated on the basis of
their characteristic ﬂuorescence at the wavelengths of 325/440 nm, 330/415 nm, 325/434 nm and 365/480 nm, respectively
[24]. Two hundred microliters of aliquots were applied to a 96-
well plate.
Content of amyloid cross-β structure
Formation of amyloid cross-β structure was measured using
thioﬂavin T [25,26]. Brieﬂy, 5 μl of 640 mM thioﬂavin T in 0.1 M
sodium phosphate buffer, pH 7.4, were added to 95 μl of a sample.
The ﬂuorescence intensity was measured at excitation/emission
wavelengths of 435/485 nm after 1-h incubation at room tem-
perature. Fluorescence measurements were made in an Inﬁnite
200 PRO multimode reader (Tecan Group Ltd., Männedorf,
Switzerland).
Electron paramagnetic resonance (EPR) spectroscopy
ESR spectra of samples at “time 0” (ca 30 min after formulation
of the incubation media) and after 6 days were analysed using a
Bruker FT-EPR spectrometer ELEXSYS E580 (Teaching Center of
Microelectronics and Nanotechnology, University of Rzeszów).
50 ml of each sample was introduced into a capillary tube for EPR
measurement (non-heparinized microhematocrit tubes 75 μL;
1.5575 mm; Medlab Products, Raszyn, Poland). Sample capil-
laries were placed into a quartz EPR sample tube and centered in a
standard rectangular microwave cavity under critical coupling
conditions. The spectrometer operated at X-band (9.850537 GHz).
The following settings were used: central ﬁeld, 3507.00 G; mod-
ulation amplitude, 0.3 G; modulation frequency, 100 kHz; micro-
wave power, 94.64 mW; power attenuation 2.0 dB; scan range,
50 G; conversion time, 25 ms; sweep time, 25.6 s. Two scans were
typically accumulated to intensify the signals observed. The
spectra were recorded and analysed using Xepr software. The
signal was integrated twice to determine its area, and thus the
concentration of the radical.
Statistical analysis
All the experiments were done at least in triplicate. Data were
shown in the form of mean values and standard deviations. The
statistical analysis of the data was performed using STATISTICA
software package (version 10, StatSoft Inc. 2010, Tulsa, OK, USA,
www.statsoft.com). Differences between means were analysed
using Student's t–test for independent samples and were con-
sidered signiﬁcant or highly signiﬁcant at ▲p-values o0.05,
#p-values o0.01 and *p-valueso 0.001.Results and discussion
Ascorbic acid is present in blood plasma at relatively low con-
centrations (about 50 mM) [3,27] but can be accumulated in some
cells expressing SVCT1 or SVCT2 transporter up to millimolar
concentrations [28,29]. We chose an intermediate concentration of
1 mM for routine studies of the AA-induced glycation in vitro.
Studies of the kinetics of AA-induced AGE formation showed a
hyperbolic-type course of the reaction, reaching saturation after
several days. The increase in the level of AGEs was parallelled by
increases in the levels of dityrosine, N′-formylkynurenine and
kynurenine, indicating that protein glycation was accompanied by
oxidative changes, in agreement with the idea of glycoxidation.
Interestingly, DMSO enhanced the rate of AA-induced glycoxida-
tion. The measurements of the formation of amyloid cross-β
structure were less reproducible showing a high day-to-day var-
iation. DMSO inhibited rather than enhanced amyloid cross-β
structure formation (Fig. 1). On the basis of kinetic data, the
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Fig. 1. Kinetics of glycoxidation of BSA by ascorbic acid as measured by ﬂuorimetric parameters of protein modiﬁcation.
I. Sadowska-Bartosz et al. / Redox Biology 6 (2015) 93–99 95incubation time of 6 days was chosen for the routine studies of the
effects of additives on the initial stage BSA glycoxidation.
Glycoxidation of BSA by AA was enhanced by SOD (unlike
glycation induced by glucose, fructose or ribose) [17] but not af-
fected by CAT (Table 1).We checked the effect of chosen additives, known to affect BSA
glycoxidation by sugars and aldehydes [17–20], on BSA glycox-
idation by AA. Metal chelators did not decrease the extent of BSA
modiﬁcations or even augmented them. On the other hand, anti-
oxidants, in particular polyphenols were efﬁcient in preventing
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Fig. 1. (continued)
I. Sadowska-Bartosz et al. / Redox Biology 6 (2015) 93–9996glycoxidation. Interestingly, 1-cyano-4-hydroxycinnamic acid, in
contrast to 4-hydroxycinnamic acid, was an efﬁcient inhibitor of
AA-induced glycation like in the case of glycation induced by su-
gars [19] and reactive aldehydes [18]. As noted previously [19], the
effects of additives on changes in the ﬂuorescence of AGEs, dityr-
osine and N’-formylkunurenine were similar, while those on the
kynurenine ﬂuorescence were less concordant. Effects of additives,
especially polyphenols, on BSA modiﬁcations measured with
thioﬂavine T were also divergent in many cases from those due to
formation of AGEs and amino acid modiﬁcations (Table 2).
As ﬂuorimetric measurements of glycation may be due to in-
terference by the additives, we checked the extent of BSA glycation
using an ELISA kit for chosen compounds. The results obtained are
in general agreement with those obtained by ﬂuorimetry, con-
ﬁrming, i.a., protection against glycation by FeCl3, 1-cyano-4-hy-
droxycinnamic acid, caffeic acid, ferulic acid, genistein, naringin,
propyl gallate and rutin (Fig. 2 vs Table 2). A similar conclusion has
been drawn in our previous studies of glycation induced by sugars
[19].
We evaluated also the effects of oxidants on AA-induced gly-
coxidation. Among the oxidants employed, AAPH signiﬁcantly
enhanced glycoxidation but hydrogen peroxide was without effect
and FeCl3 even decreased the extent of glycoxidation.
We have reported previously that nitroxides, especially tetra-
methylpiperidine derivatives, protect against glycation induced byglucose [19]. These compounds proved completely ineffective in
protecting against AA-induced glycation (Table 2).
These results are generally in agreement with the view that
products of AA oxidation and not AA itself induce protein gly-
coxidation. Enhancement of AA-induced glycoxidation by AAPH
appears to be due to one-electron oxidation of AA by peroxyl ra-
dicals generated upon thermal decomposition of this compound
[30]. The lack of effect of nitroxides, contrasting with their effects
on glucose-induced glycoxidation, seems to be due to AA oxidation
by these compounds [31]. Augmentation of glycoxidation by
DMSO may be ascribed to oxidation of AA by DMSO; such an effect
has been reported previously [32]. We did not observe aby in-
crease in the extent of glycation induced by hydrogen peroxide. It
has been reported that hydrogen peroxide, even at much lower
concentrations than that used in the present study, enhanced
human serum albumin glycation induced by glucose [33]; the
reasons for this discrepancy are unclear but the lack of effect of
exogenous H2O2 observed in this study is consistent with the lack
of effect of CAT. The lack of augmentation of glycoxidation by FeCl3
is puzzling and may be attributed mainly to low availability of iron
in the reaction medium (0.1 M phosphate buffer). Moreover, re-
duction of Fe3þ by an equimolar concentration of ascorbate pro-
duces Fe2þ which is a reductant and can act as an antioxidant.
Augmentation of glycoxidation by superoxide dismutase is also
not easy to explain. SOD could be a source of copper which is an
Table 1
Effect of additives on ﬂuorimetric parameters of glycoxidative modiﬁcations of BSA. MeanþSD.
Additive AGE Dityrosine N′-formylkynurenine Kynurenine Thioﬂavin T
BSA 7.19 74.11* 4.9972.74* 7.1874.12* 9.26 74.79* 12.0675.47*
BSAþascorbic acid, no additive 100 100 100 100 100
DMSO 157.86711.33* 185.23710.62* 166.92713.12* 140.6079.14Δ 46.93714.48Δ
Antioxidants
Captopril 1 mM 80.0476.15Δ 84.2275.78Δ 86.377 6.35# 105.5177.62 77.06711.53#
Tiron 1 mM 47.0077.15* 48.45710.40Δ 40.0375.67* 100.5673.23 136.80724.19
Trolox 1 mM 46.23 70.38* 35.3570.52* 44.0771.48* 110.1471.41* 35.59726.85#
Metal chelators
EDTA 1 mM 126.9976.04Δ 135.2977.76Δ 130.0277.38Δ 134.7977.81Δ 186.99715.27*
EGTA 1 mM 101.8172.65 102.7275.81 105.2578.94 95.6876.53 73.2576.04Δ
DTPA 1 mM 145.1278.08* 156.6775.78* 149.5776.02* 148.85716.85Δ 31.93739.78#
NTA 1mM 110.41712.98 119.76712.84 113.27710.90 111.70711.36 176.30731.27#
Organic acids
1-Cyano-4-hydroxycinnamic acid 1 mM 4.2470.20* 3.0770.16* 3.3270.47* 9.7170.81* 64.01720.36#
4-Hydroxycinnamic acid 1 mM 107.3576.65 109.0176.04 111.2677.49 110.7377.30 55.30718.55#
Polyphenols
Caffeic acid 1 mM o0* o0* o0* o0* 261.65 7 20.65*
Ellagic acid 1 mM 52.7170.81* 28.6270.45* 46.9470.62* 89.6372.07* 519.37729.54*
Ferulic acid 1 mM o0* 15.4374.28 o0* 166.4473.25 45.16712.69Δ
Gallic acid 1 mM 191.78 73.17* 105.6873.46# 188.74 74.13* 284.0278.56 176.77 716.98Δ
Genistein 1 mM 8.74 70.42* 6.437 0.35* 7.85 7 0.45* 16.9070.40* 359.27725.08*
Genkwanin 1 mM 25.8975.12* 18.95 73.25* 25.41 75.48* 23.91 79.77* o0*
Naringin 1 mM 20.18 7 0.72* 13.12 7 0.35* 17.47 7 0.43* 99.14 7 1.28 319.05 7 25.32*
Propyl gallate 1 mM o0* o0* o0* 70.17 72.08* 233.83732.31Δ
Quercetin 1 mM 21.2170.10* 11.2170.14* 19.8270.10* 79.6071.90* 403.74 728.77*
Rutin 1 mM 2.61 70.22* 1.4870.13* 1.7670.25* 3.0870.16* 7.56 73.80*
Oxidants
AAPH 5 mM 367.67710.24* 349.0479.40* 374.63712.31* 525.06718.21* 689.92713.59*
FeCl3 1 mM 57.7771.54* 64.1271.33* 64.0072.87* 94.0271.66Δ 180.82712.86*
H2O2 0.1 mM 101.86 77.17 99.7877.24 98.1576.87 100.1975.19 124.15714.87#
Nitroxides
TEMPO 0.05 mM 116.1873.51Δ 120.3174.68Δ 118.3073.77Δ 104.6174.75 134.19714.23Δ
TEMPO 0.1 mM 111.5275.12# 114.20 73.14Δ 110.0175.24# 101.19 74.68 82.81720.48
TEMPO 0.2 mM 110.97 7 4.49# 113.17 7 3.93Δ 111.73 7 2.01* 101.61 7 3.58 144.07 7 18.13Δ
TEMPO 0.5 mM 102.9875.56 104.5074.26 105.19 74.85 91.31 75.18# 139.83715.44Δ
TEMPO 1 mM 97.27 74.54 98.3974.17 100.15 7 5.22 85.8775.6# 138.61 719.08Δ
4-Hydroxy-TEMPO 0.05 mM 128.54 7 6.06Δ 128.18 7 3.52* 127.75 7 4.21* 118.00 7 6.64Δ 114.30 7 11.47
4-Hydroxy-TEMPO 0.1 m mM 122.91 76.78Δ 123.9375.67Δ 123.68 7 4.63* 105.89 75.65 75.75 715.24
4-Hydroxy-TEMPO 0.2 mM 119.29 7 5.46Δ 123.14 7 4.11* 120.58 7 4.68Δ 108.89 7 5.24# 124.05 714.73Δ
4-Hydroxy-TEMPO 0.5 mM 117.19 7 7.77# 118.36 75.43Δ 117.86 76.76# 102.44 74.19 176.33 7 13.67*
4-Hydroxy-TEMPO 1 mM 113.32 712.39 112.37 79.83 110.5076.87 100.2479.18 145.35719.59Δ
4-Carboxy-TEMPO 0.05 mM 93.79 74.53 90.36 72.67Δ 91.83 72.7 100.1973.44 380.08 730.19*
4-Carboxy-TEMPO 0.1mmM 108.4073.61# 104.5671.99# 106.09 72.4# 114.0371.8* 328.22 742.91*
4-Carboxy-TEMPO 0.2 mM 120.1975.37Δ 118.6375.74Δ 119.83 73.88* 119.7475.15Δ 336.72 738.29*
4-Carboxy-TEMPO 0.5 mM 120.7672.18* 120.0672.18* 119.8073.28* 115.2673.93Δ 133.4 723.03
4-Carboxy-TEMPO 1 mM 120.2672.69* 119.39 72.07* 118.43 72.38* 111.5071.74* 122.41721.2
Compounds written in italics were dissolved in DMSO and compared with samples incubated with AA and DMSO. * po0.001 (with respect to BSA incubated with AA
alone).
Δ po0.01 (with respect to BSA incubated with AA alone).
# po0.05 (with respect to BSA incubated with AA alone).
Table 2
Effect of SOD and catalase on the glycoxidation of BSA by ascorbic acid. The increase in the values of glycoxidation parameters induced by 1 mM AA alone assumed as 100%.
Mean valuesþSD.
AGE [%] Dityrosine [%] N′-formylkynurenine [%] Kynurenine [%]
SOD [10 mg/ml] 137.3716.2 142.177.4 139.7 77.3 145.275.7
Catalase [10 mg/ml] 99.978.4 97.778.9 95.6 710.2 97.9 711.7
I. Sadowska-Bartosz et al. / Redox Biology 6 (2015) 93–99 97efﬁcient oxidant of AA; however, 10 mg/ml CuZnSOD can provide
about 0.6 mM copper even if losing all its copper. SOD has been
shown to have a thiol oxidase activity [34] but no analogous ac-
tivity of this enzyme has been reported with respect to AA
oxidation.
An alternative explanation for the effect of SOD may base onthe idea that ascorbyl radical plays a role in initiating glycation and
that SOD affects the rate of formation of the ascorbyl radical. If AA
autoxidizes by one-electron reaction with oxygen,
AA O AA O2 2+ ⇄ +• −•
SOD, by dismutating the superoxide radical, drives the reaction
Fig. 2. Effect of selected additives on the extent of BSA glycation as estimated by ELISA.
Fig. 4. Correlation between the level of AGEs estimated ﬂuorimetrically and re-
lative concentration of ascorbyl radicals in BSA samples incubated with AA and
various additives.
I. Sadowska-Bartosz et al. / Redox Biology 6 (2015) 93–9998forward. An analogous mechanism has been proposed for the role
of SOD in quinone autoxidation [35].
Protection by antioxidants can be ascribed to their keeping AA
in the reduced state or reducing its oxidations product(s).
Ascorbyl radical is generally thought to be inert and its inert-
ness due to delocalization of the odd electron is believed to be the
basis of the antioxidant activity. However, it can be postulated that
it can still enter into reactions with proteins. leading to attach-
ment of the ascorbyl of AA. One-electron redox potential of the
ascorbyl radical/AA redox pair ascorbyl radical/AA is low
(þ282 mV) [36] but, nevertheless, it can enter both one-electron
oxidation and reduction reactions with proteins or ascorbyl radical
can attach to a protein.
If ascorbyl radical plays a role in the AA-induced glycation, a
relationship between the steady-state level of this radical in the
presence of glycation inhibitors and their inhibitory activity should
be observed. We studied the relationship between the AGE level
and the steady-state concentration of ascorbyl radical for 20 sub-
stances affecting the rate of glycation yielded a highly signiﬁcant
(po0.001) correlation coefﬁcient (R¼0.78) (Figs. 3 and 4). Thus, itFig. 3. Relative concentration of ascorbyl radical in BSA incubated with Acan be suggested that ascorbyl radical is the primary agent indu-
cing glycation by AA and decrease in the steady-state concentra-
tion of this radical determines the protective effect against AA-
induced glycation. The lack of effects of SOD and catalase suggestsA and various additives. Inset: ESR spectrum of the ascorbyl radical.
I. Sadowska-Bartosz et al. / Redox Biology 6 (2015) 93–99 99that the ascorbyl radical and not reactive oxygen species produced
during AA autoxidation are crucial in the process of AA-induce
protein glycation. Flavonoids and many other antioxidants can
regenerate AA from the ascorbyl radical [37] while compounds
lacking this activity did not affect glycation.
If our hypothesis is true, it would extend the list of AA oxidation
products able to initiate glycation and contribute to explanation of the
differences between glycation in vivo and in vitro. In vivo ascorbyl
radical can be subject to non-enzymatic or enzymatic regeneration. In
the cytosol, it is reconverted to AA by cytochrome b5 reductase and
thioredoxin reductase in reactions involving NADH and NADPH, re-
spectively [38]. The transmembrane redox system may enable ex-
tracellular reduction of the ascorbyl radical [39,40]. Therefore, chances
of their reactions with proteins are much lower than in in simple in
vitro systems. Disproportionation of ascorbyl radical, also more
probable in the latter case, leads to formation of DHA and products of
its decomposition which are known glycating agents. In some regions
of the body (e.g. lens), where concentration of AA is high and possi-
bilities of regeneration of ascorbyl radical are limited, especially under
stress conditions, ascorbyl radical and further oxidation products of
AA may also become glycating agents. Further studies are required to
demonstrate experimentally the reactivity of ascorbyl radicals for
proteins and initiation of protein glycation by these radicals.Acknowledgment
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